NIH Study Identifies Key Immune Pathway in Inflammatory Bowel Disease Defense

Researchers at the National Institutes of Health have uncovered a significant regulatory mechanism in the immune system that protects against chronic intestinal inflammation. Their findings link specific GPR15 gene mutations to severe, early-onset inflammatory bowel disease. This discovery offers valuable insights into immune cell function, potentially leading to better diagnostic tools and more targeted therapies for IBD.